Nivolumab,Ipilimumab,Cisplatin,Vinorelbine,Gemcitabine,Docetaxel,Pemetrexed,Carboplatin,Paclitaxel,Durvalumab,Toripalimab
Coherus,Junshi Biosciences,bms,Astrazeneca
['nsclc', 'sclc', 'lcsm,(-blcsm)']
perioperative chemo-inmmunotherapy should be the standard treatment in stage ib- iii nsclc. #asco2023 #lcsm 
Associate Head Oncology. Fundación Jiménez Díaz. IIS - FJD. Head of Thoracic Oncology & Clinical Trials. Professor  @UAM_Madrid previously @RoyalFreeNHS London